These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 29722062)

  • 21. Chemical Effect of Bisphenol A on Non-Alcoholic Fatty Liver Disease.
    Dallio M; Diano N; Masarone M; Gravina AG; Patanè V; Romeo M; Di Sarno R; Errico S; Nicolucci C; Abenavoli L; Scarpellini E; Boccuto L; Persico M; Loguercio C; Federico A
    Int J Environ Res Public Health; 2019 Aug; 16(17):. PubMed ID: 31466361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adoption of New Glucose-Lowering Medications in the U.S.-The Case of SGLT2 Inhibitors: Nationwide Cohort Study.
    McCoy RG; Dykhoff HJ; Sangaralingham L; Ross JS; Karaca-Mandic P; Montori VM; Shah ND
    Diabetes Technol Ther; 2019 Dec; 21(12):702-712. PubMed ID: 31418588
    [No Abstract]   [Full Text] [Related]  

  • 23. Glycaemic target attainment in people with Type 2 diabetes treated with insulin glargine/lixisenatide fixed-ratio combination: a post hoc analysis of the LixiLan-O and LixiLan-L trials.
    Davidson JA; Desouza C; Fonseca V; Frias JP; Van Gaal L; Giorgino F; Chao J; Dex TA; Roberts M; Saremi A; Leiter LA
    Diabet Med; 2020 Feb; 37(2):256-266. PubMed ID: 31365765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials.
    Anstee QM; Lawitz EJ; Alkhouri N; Wong VW; Romero-Gomez M; Okanoue T; Trauner M; Kersey K; Li G; Han L; Jia C; Wang L; Chen G; Subramanian GM; Myers RP; Djedjos CS; Kohli A; Bzowej N; Younes Z; Sarin S; Shiffman ML; Harrison SA; Afdhal NH; Goodman Z; Younossi ZM
    Hepatology; 2019 Nov; 70(5):1521-1530. PubMed ID: 31271665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update.
    Sarin SK; Choudhury A; Sharma MK; Maiwall R; Al Mahtab M; Rahman S; Saigal S; Saraf N; Soin AS; Devarbhavi H; Kim DJ; Dhiman RK; Duseja A; Taneja S; Eapen CE; Goel A; Ning Q; Chen T; Ma K; Duan Z; Yu C; Treeprasertsuk S; Hamid SS; Butt AS; Jafri W; Shukla A; Saraswat V; Tan SS; Sood A; Midha V; Goyal O; Ghazinyan H; Arora A; Hu J; Sahu M; Rao PN; Lee GH; Lim SG; Lesmana LA; Lesmana CR; Shah S; Prasad VGM; Payawal DA; Abbas Z; Dokmeci AK; Sollano JD; Carpio G; Shresta A; Lau GK; Fazal Karim M; Shiha G; Gani R; Kalista KF; Yuen MF; Alam S; Khanna R; Sood V; Lal BB; Pamecha V; Jindal A; Rajan V; Arora V; Yokosuka O; Niriella MA; Li H; Qi X; Tanaka A; Mochida S; Chaudhuri DR; Gane E; Win KM; Chen WT; Rela M; Kapoor D; Rastogi A; Kale P; Rastogi A; Sharma CB; Bajpai M; Singh V; Premkumar M; Maharashi S; Olithselvan A; Philips CA; Srivastava A; Yachha SK; Wani ZA; Thapa BR; Saraya A; Shalimar ; Kumar A; Wadhawan M; Gupta S; Madan K; Sakhuja P; Vij V; Sharma BC; Garg H; Garg V; Kalal C; Anand L; Vyas T; Mathur RP; Kumar G; Jain P; Pasupuleti SSR; Chawla YK; Chowdhury A; Alam S; Song DS; Yang JM; Yoon EL;
    Hepatol Int; 2019 Jul; 13(4):353-390. PubMed ID: 31172417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal multi-omics of host-microbe dynamics in prediabetes.
    Zhou W; Sailani MR; Contrepois K; Zhou Y; Ahadi S; Leopold SR; Zhang MJ; Rao V; Avina M; Mishra T; Johnson J; Lee-McMullen B; Chen S; Metwally AA; Tran TDB; Nguyen H; Zhou X; Albright B; Hong BY; Petersen L; Bautista E; Hanson B; Chen L; Spakowicz D; Bahmani A; Salins D; Leopold B; Ashland M; Dagan-Rosenfeld O; Rego S; Limcaoco P; Colbert E; Allister C; Perelman D; Craig C; Wei E; Chaib H; Hornburg D; Dunn J; Liang L; Rose SMS; Kukurba K; Piening B; Rost H; Tse D; McLaughlin T; Sodergren E; Weinstock GM; Snyder M
    Nature; 2019 May; 569(7758):663-671. PubMed ID: 31142858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced burden of diabetes and improved quality of life: Experiences from unrestricted day-and-night hybrid closed-loop use in very young children with type 1 diabetes.
    Musolino G; Dovc K; Boughton CK; Tauschmann M; Allen JM; Nagl K; Fritsch M; Yong J; Metcalfe E; Schaeffer D; Fichelle M; Schierloh U; Thiele AG; Abt D; Kojzar H; Mader JK; Slegtenhorst S; Ashcroft N; Wilinska ME; Sibayan J; Cohen N; Kollman C; Hofer SE; Fröhlich-Reiterer E; Kapellen TM; Acerini CL; de Beaufort C; Campbell F; Rami-Merhar B; Hovorka R;
    Pediatr Diabetes; 2019 Sep; 20(6):794-799. PubMed ID: 31140654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD.
    Boursier J; Guillaume M; Leroy V; Irlès M; Roux M; Lannes A; Foucher J; Zuberbuhler F; Delabaudière C; Barthelon J; Michalak S; Hiriart JB; Peron JM; Gerster T; Le Bail B; Riou J; Hunault G; Merrouche W; Oberti F; Pelade L; Fouchard I; Bureau C; Calès P; de Ledinghen V
    J Hepatol; 2019 Aug; 71(2):389-396. PubMed ID: 31102719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes.
    Niewczas MA; Pavkov ME; Skupien J; Smiles A; Md Dom ZI; Wilson JM; Park J; Nair V; Schlafly A; Saulnier PJ; Satake E; Simeone CA; Shah H; Qiu C; Looker HC; Fiorina P; Ware CF; Sun JK; Doria A; Kretzler M; Susztak K; Duffin KL; Nelson RG; Krolewski AS
    Nat Med; 2019 May; 25(5):805-813. PubMed ID: 31011203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Peripheral Blood DNA Methylation Signature of Hepatic Fat Reveals a Potential Causal Pathway for Nonalcoholic Fatty Liver Disease.
    Ma J; Nano J; Ding J; Zheng Y; Hennein R; Liu C; Speliotes EK; Huan T; Song C; Mendelson MM; Joehanes R; Long MT; Liang L; Smith JA; Reynolds LM; Ghanbari M; Muka T; van Meurs JBJ; Alferink LJM; Franco OH; Dehghan A; Ratliff S; Zhao W; Bielak L; Kardia SLR; Peyser PA; Ning H; VanWagner LB; Lloyd-Jones DM; Carr JJ; Greenland P; Lichtenstein AH; Hu FB; Liu Y; Hou L; Darwish Murad S; Levy D
    Diabetes; 2019 May; 68(5):1073-1083. PubMed ID: 30936141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis.
    Li J; Zou B; Yeo YH; Feng Y; Xie X; Lee DH; Fujii H; Wu Y; Kam LY; Ji F; Li X; Chien N; Wei M; Ogawa E; Zhao C; Wu X; Stave CD; Henry L; Barnett S; Takahashi H; Furusyo N; Eguchi Y; Hsu YC; Lee TY; Ren W; Qin C; Jun DW; Toyoda H; Wong VW; Cheung R; Zhu Q; Nguyen MH
    Lancet Gastroenterol Hepatol; 2019 May; 4(5):389-398. PubMed ID: 30902670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chinese clinical guidelines for continuous glucose monitoring (2018 edition).
    Bao Y; Chen L; Chen L; Dou J; Gao Z; Gao L; Guo L; Guo X; Ji L; Ji Q; Jia W; Kuang H; Li Q; Li Q; Li X; Li Y; Li L; Liu J; Ma J; Ran X; Shi L; Song G; Wang Y; Weng J; Xiao X; Xie Y; Xi G; Yang L; Zhao Z; Zhou J; Zhou Z; Zhu D; Zou D;
    Diabetes Metab Res Rev; 2019 Sep; 35(6):e3152. PubMed ID: 30884108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States.
    Saran R; Robinson B; Abbott KC; Agodoa LYC; Bragg-Gresham J; Balkrishnan R; Bhave N; Dietrich X; Ding Z; Eggers PW; Gaipov A; Gillen D; Gipson D; Gu H; Guro P; Haggerty D; Han Y; He K; Herman W; Heung M; Hirth RA; Hsiung JT; Hutton D; Inoue A; Jacobsen SJ; Jin Y; Kalantar-Zadeh K; Kapke A; Kleine CE; Kovesdy CP; Krueter W; Kurtz V; Li Y; Liu S; Marroquin MV; McCullough K; Molnar MZ; Modi Z; Montez-Rath M; Moradi H; Morgenstern H; Mukhopadhyay P; Nallamothu B; Nguyen DV; Norris KC; O'Hare AM; Obi Y; Park C; Pearson J; Pisoni R; Potukuchi PK; Repeck K; Rhee CM; Schaubel DE; Schrager J; Selewski DT; Shamraj R; Shaw SF; Shi JM; Shieu M; Sim JJ; Soohoo M; Steffick D; Streja E; Sumida K; Kurella Tamura M; Tilea A; Turf M; Wang D; Weng W; Woodside KJ; Wyncott A; Xiang J; Xin X; Yin M; You AS; Zhang X; Zhou H; Shahinian V
    Am J Kidney Dis; 2019 Mar; 73(3 Suppl 1):A7-A8. PubMed ID: 30798791
    [No Abstract]   [Full Text] [Related]  

  • 34. International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.
    Danne T; Garg S; Peters AL; Buse JB; Mathieu C; Pettus JH; Alexander CM; Battelino T; Ampudia-Blasco FJ; Bode BW; Cariou B; Close KL; Dandona P; Dutta S; Ferrannini E; Fourlanos S; Grunberger G; Heller SR; Henry RR; Kurian MJ; Kushner JA; Oron T; Parkin CG; Pieber TR; Rodbard HW; Schatz D; Skyler JS; Tamborlane WV; Yokote K; Phillip M
    Diabetes Care; 2019 Jun; 42(6):1147-1154. PubMed ID: 30728224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK.
    Williams R; Alexander G; Aspinall R; Batterham R; Bhala N; Bosanquet N; Severi K; Burton A; Burton R; Cramp ME; Day N; Dhawan A; Dillon J; Drummond C; Dyson J; Ferguson J; Foster GR; Gilmore I; Greenberg J; Henn C; Hudson M; Jarvis H; Kelly D; Mann J; McDougall N; McKee M; Moriarty K; Morling J; Newsome P; O'Grady J; Rolfe L; Rice P; Rutter H; Sheron N; Thorburn D; Verne J; Vohra J; Wass J; Yeoman A
    Lancet; 2018 Dec; 392(10162):2398-2412. PubMed ID: 30473364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic R2* is more strongly associated with proton density fat fraction than histologic liver iron scores in patients with nonalcoholic fatty liver disease.
    Bashir MR; Wolfson T; Gamst AC; Fowler KJ; Ohliger M; Shah SN; Alazraki A; Trout AT; Behling C; Allende DS; Loomba R; Sanyal A; Schwimmer J; Lavine JE; Shen W; Tonascia J; Van Natta ML; Mamidipalli A; Hooker J; Kowdley KV; Middleton MS; Sirlin CB;
    J Magn Reson Imaging; 2019 May; 49(5):1456-1466. PubMed ID: 30318834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First Genome-Wide Association Study of Latent Autoimmune Diabetes in Adults Reveals Novel Insights Linking Immune and Metabolic Diabetes.
    Cousminer DL; Ahlqvist E; Mishra R; Andersen MK; Chesi A; Hawa MI; Davis A; Hodge KM; Bradfield JP; Zhou K; Guy VC; Åkerlund M; Wod M; Fritsche LG; Vestergaard H; Snyder J; Højlund K; Linneberg A; Käräjämäki A; Brandslund I; Kim CE; Witte D; Sørgjerd EP; Brillon DJ; Pedersen O; Beck-Nielsen H; Grarup N; Pratley RE; Rickels MR; Vella A; Ovalle F; Melander O; Harris RI; Varvel S; Grill VER; ; Hakonarson H; Froguel P; Lonsdale JT; Mauricio D; Schloot NC; Khunti K; Greenbaum CJ; Åsvold BO; Yderstræde KB; Pearson ER; Schwartz S; Voight BF; Hansen T; Tuomi T; Boehm BO; Groop L; Leslie RD; Grant SFA
    Diabetes Care; 2018 Nov; 41(11):2396-2403. PubMed ID: 30254083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis.
    Strnad P; Buch S; Hamesch K; Fischer J; Rosendahl J; Schmelz R; Brueckner S; Brosch M; Heimes CV; Woditsch V; Scholten D; Nischalke HD; Janciauskiene S; Mandorfer M; Trauner M; Way MJ; McQuillin A; Reichert MC; Krawczyk M; Casper M; Lammert F; Braun F; von Schönfels W; Hinz S; Burmeister G; Hellerbrand C; Teufel A; Feldman A; Schattenberg JM; Bantel H; Pathil A; Demir M; Kluwe J; Boettler T; Ridinger M; Wodarz N; Soyka M; Rietschel M; Kiefer F; Weber T; Marhenke S; Vogel A; Hinrichsen H; Canbay A; Schlattjan M; Sosnowsky K; Sarrazin C; von Felden J; Geier A; Deltenre P; Sipos B; Schafmayer C; Nothnagel M; Aigner E; Datz C; Stickel F; Morgan MY; Hampe J; Berg T; Trautwein C
    Gut; 2019 Jun; 68(6):1099-1107. PubMed ID: 30068662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial.
    Solomon SD; Rizkala AR; Lefkowitz MP; Shi VC; Gong J; Anavekar N; Anker SD; Arango JL; Arenas JL; Atar D; Ben-Gal T; Boytsov SA; Chen CH; Chopra VK; Cleland J; Comin-Colet J; Duengen HD; Echeverría Correa LE; Filippatos G; Flammer AJ; Galinier M; Godoy A; Goncalvesova E; Janssens S; Katova T; Køber L; Lelonek M; Linssen G; Lund LH; O'Meara E; Merkely B; Milicic D; Oh BH; Perrone SV; Ranjith N; Saito Y; Saraiva JF; Shah S; Seferovic PM; Senni M; Sibulo AS; Sim D; Sweitzer NK; Taurio J; Vinereanu D; Vrtovec B; Widimský J; Yilmaz MB; Zhou J; Zweiker R; Anand IS; Ge J; Lam CSP; Maggioni AP; Martinez F; Packer M; Pfeffer MA; Pieske B; Redfield MM; Rouleau JL; Van Veldhuisen DJ; Zannad F; Zile MR; McMurray JJV
    Circ Heart Fail; 2018 Jul; 11(7):e004962. PubMed ID: 29980595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brown Adipocyte-Specific PPARγ (Peroxisome Proliferator-Activated Receptor γ) Deletion Impairs Perivascular Adipose Tissue Development and Enhances Atherosclerosis in Mice.
    Xiong W; Zhao X; Villacorta L; Rom O; Garcia-Barrio MT; Guo Y; Fan Y; Zhu T; Zhang J; Zeng R; Chen YE; Jiang Z; Chang L
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1738-1747. PubMed ID: 29954752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.